Siegfried Holding AG (0QQO.L)
CHF 978.56
(0.57%)
CHF 978.56
(0.57%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 1.02 Billion CHF | -5.44% |
| 2022 | 1.08 Billion CHF | 2.01% |
| 2021 | 1.06 Billion CHF | 42.1% |
| 2020 | 746.62 Million CHF | 1.86% |
| 2019 | 733.01 Million CHF | 72.75% |
| 2018 | 424.33 Million CHF | 5.24% |
| 2017 | 403.21 Million CHF | 11.81% |
| 2016 | 360.62 Million CHF | -29.47% |
| 2015 | 511.28 Million CHF | 107.16% |
| 2014 | 246.8 Million CHF | 40.76% |
| 2013 | 175.33 Million CHF | 8.9% |
| 2012 | 161 Million CHF | 105.6% |
| 2011 | 78.31 Million CHF | -13.31% |
| 2010 | 90.33 Million CHF | -39.66% |
| 2009 | 149.72 Million CHF | -18.07% |
| 2008 | 182.74 Million CHF | 2.12% |
| 2007 | 178.95 Million CHF | -27.1% |
| 2006 | 245.49 Million CHF | 0.69% |
| 2005 | 243.82 Million CHF | 24.61% |
| 2004 | 195.66 Million CHF | -20.17% |
| 2003 | 245.09 Million CHF | 9.94% |
| 2002 | 222.92 Million CHF | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 971.24 Million CHF | 0.0% |
| 2023 Q2 | 1.04 Billion CHF | 0.0% |
| 2023 Q4 | 1.02 Billion CHF | 0.0% |
| 2023 FY | 1.02 Billion CHF | -5.44% |
| 2022 Q4 | 1.08 Billion CHF | 0.0% |
| 2022 FY | 1.08 Billion CHF | 2.01% |
| 2022 Q2 | 1.08 Billion CHF | 0.0% |
| 2021 Q2 | 1.03 Billion CHF | 0.0% |
| 2021 Q4 | 1.06 Billion CHF | 0.0% |
| 2021 FY | 1.06 Billion CHF | 42.1% |
| 2020 Q4 | 746.62 Million CHF | 0.0% |
| 2020 FY | 746.62 Million CHF | 1.86% |
| 2020 Q2 | 730.91 Million CHF | 0.0% |
| 2019 Q4 | 733.01 Million CHF | 0.0% |
| 2019 FY | 733.01 Million CHF | 72.75% |
| 2019 Q2 | 660.89 Million CHF | 0.0% |
| 2018 Q4 | 424.33 Million CHF | 0.0% |
| 2018 FY | 424.33 Million CHF | 5.24% |
| 2018 Q2 | 387.39 Million CHF | 0.0% |
| 2017 Q2 | 359.3 Million CHF | 0.0% |
| 2017 Q4 | 403.21 Million CHF | 0.0% |
| 2017 FY | 403.21 Million CHF | 11.81% |
| 2016 Q2 | 536.27 Million CHF | 0.0% |
| 2016 Q4 | 360.62 Million CHF | 0.0% |
| 2016 FY | 360.62 Million CHF | -29.47% |
| 2015 Q2 | 287.94 Million CHF | 0.0% |
| 2015 Q4 | 511.28 Million CHF | 0.0% |
| 2015 FY | 511.28 Million CHF | 107.16% |
| 2014 Q4 | 246.8 Million CHF | 0.0% |
| 2014 FY | 246.8 Million CHF | 40.76% |
| 2014 Q2 | 174.01 Million CHF | 0.0% |
| 2013 Q2 | 159.61 Million CHF | 0.0% |
| 2013 Q4 | 175.33 Million CHF | 0.0% |
| 2013 FY | 175.33 Million CHF | 8.9% |
| 2012 Q2 | 150.61 Million CHF | 0.0% |
| 2012 FY | 161 Million CHF | 105.6% |
| 2012 Q4 | 161 Million CHF | 0.0% |
| 2011 Q2 | 70.93 Million CHF | 0.0% |
| 2011 Q4 | 78.31 Million CHF | 0.0% |
| 2011 FY | 78.31 Million CHF | -13.31% |
| 2010 Q2 | 106.92 Million CHF | 0.0% |
| 2010 Q4 | 90.33 Million CHF | 0.0% |
| 2010 FY | 90.33 Million CHF | -39.66% |
| 2009 Q4 | 149.72 Million CHF | 0.0% |
| 2009 FY | 149.72 Million CHF | -18.07% |
| 2008 FY | 182.74 Million CHF | 2.12% |
| 2007 FY | 178.95 Million CHF | -27.1% |
| 2006 FY | 245.49 Million CHF | 0.69% |
| 2005 FY | 243.82 Million CHF | 24.61% |
| 2004 FY | 195.66 Million CHF | -20.17% |
| 2003 FY | 245.09 Million CHF | 9.94% |
| 2002 FY | 222.92 Million CHF | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Relief Therapeutics Holding AG | 24.16 Million CHF | -4135.457% |
| Tecan Group AG | 725.05 Million CHF | -41.144% |
| Santhera Pharmaceuticals Holding AG | 49.68 Million CHF | -1959.677% |
| Basilea Pharmaceutica AG | 183.29 Million CHF | -458.328% |
| Bachem Holding AG | 362.35 Million CHF | -182.421% |
| Molecular Partners AG | 21.92 Million CHF | -4568.024% |